nodriga 70 mg/1 tableta film tableta
alkaloid d.o.o. sarajevo - dasatinib - film tableta - 70 mg/1 tableta - 1 film tableta sadrži 70 mg dasatiniba
nodriga 140 mg/1 tableta film tableta
alkaloid d.o.o. sarajevo - dasatinib - film tableta - 140 mg/1 tableta - 1 film tableta sadrži 140 mg dasatiniba
nodriga 100 mg/1 tableta film tableta
alkaloid d.o.o. sarajevo - dasatinib - film tableta - 100 mg/1 tableta - 1 film tableta sadrži 100 mg dasatiniba
nodriga 100 mg filmom obložene tablete
alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 100 mg dasatiniba
nodriga 140 mg filmom obložene tablete
alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 140 mg dasatiniba
nodriga 20 mg filmom obložene tablete
alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 20 mg dasatiniba
nodriga 50 mg filmom obložene tablete
alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 50 mg dasatiniba
nodriga 70 mg filmom obložene tablete
alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 70 mg dasatiniba
iclusig
incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. pogledajte odjeljke 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.
kanazol 100 mg/1 kapsula kapsula, tvrda
pharmavision bh d.o.o. - itrakonazol - kapsula, tvrda - 100 mg/1 kapsula - 1 kapsula sadrži itrakonazol 100 mg